tradingkey.logo

Liquidia Says New Litigation Filed Against Co In U.S.

ReutersMay 12, 2025 11:09 AM

- Liquidia Corp LQDA.O:

  • LIQUIDIA: NEW LITIGATION FILED AGAINST CO IN U.S. ALLEGES INFRINGEMENT OF UNITED THERAPEUTICS '782 PATENT

  • LIQUIDIA: LITIGATION SEEKS TO ENJOIN LIQUIDIA FROM COMMERCIALIZING YUTREPIA IF APPROVED BY U.S. FDA

  • LIQUIDIA CORP: NEW LITIGATION DOES NOT IMPACT FDA'S ABILITY TO TAKE FINAL ACTION ON NDA FOR YUTREPIA ON PDUFA GOAL DATE OF MAY 24

  • LIQUIDIA CORP: UTHR CURRENTLY NOT SEEKING ANY INJUNCTION AGAINST FDA TO PREVENT FINAL APPROVAL OF NDA FOR YUTREPIA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI